CNL’S CNRI-H Program Continues Strong Growth Thanks to New Projects With Repare Therapeutics and Defence Therapeutics
Canada's national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program CHALK RIVER, Ontario, Jan. 20, 2025 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology organization, is pleased to announce that it is collaborating with two leading Canadian healthcare biotech companies – Repare Therapeutics and […]